loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Cimetidine Hydrochloride

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Cimetidine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ENDO REPORTS SECOND-QUARTER 2024 FINANCIAL RESULTS
    ENDO REPORTS SECOND-QUARTER 2024 FINANCIAL RESULTS

    27 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endo-reports-second-quarter-2024-financial-results-302231497.html

    PR NEWSWIRE
    27 Aug 2024
    Share Share
    ENDO ANNOUNCES CEO TRANSITION
    ENDO ANNOUNCES CEO TRANSITION

    27 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endo-announces-ceo-transition-302231342.html

    PR NEWSWIRE
    27 Aug 2024
    Share Share
    After guiding Endo through bankruptcy, CEO Blaise Coleman exits suddenly
    After guiding Endo through bankruptcy, CEO Blaise Coleman exits suddenly

    27 Aug 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/after-guiding-endo-through-chapter-11-ceo-coleman-departs-suddenly

    FIERCE PHARMA
    27 Aug 2024
    Share Share
    Endo to Host Investor Call on Second Quarter 2024 Financial Results
    Endo to Host Investor Call on Second Quarter 2024 Financial Results

    07 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endo-to-host-investor-call-on-second-quarter-2024-financial-results-302216951.html

    PR NEWSWIRE
    07 Aug 2024
    Share Share
    Pharma is Missing the Mark: Social Media's Power Proven by Physician Influencers
    Pharma is Missing the Mark: Social Media's Power Proven by Physician Influencers

    15 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharma-is-missing-the-mark-social-medias-power-proven-by-physician-influencers-302196387.html

    PR NEWSWIRE
    15 Jul 2024
    Share Share
    Endo Announces Commencement of OTCQX Trading
    Endo Announces Commencement of OTCQX Trading

    28 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endo-announces-commencement-of-otcqx-trading-302185078.html

    PR NEWSWIRE
    28 Jun 2024
    Share Share